{"disease":{"id":"combined-hyperlipidemia","name":"combined hyperlipidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03110432","title":"Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry","phase":"","overall_status":"COMPLETED","enrollment_count":1695,"lead_sponsor_name":"GWT-TUD GmbH","has_results":false},{"nct_id":"NCT05742022","title":"\"Phospholipovit\" vs Placebo in Patients With Combined Hyperlipidemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Institute of Biomedical Chemistry, Russia","has_results":false},{"nct_id":"NCT06475872","title":"Study to Evaluate the Bioequivalence of \"Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)\" and \"Crestor Tablet 5 mg (Rosuvastatin Calcium)\" in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}